ClinicalTrials.gg
RecruitingNCT06496035Updated Nov 21, 2025

Blood Flow Restriction Training in Patients With Lower Extremity Fractures

An interventional study of Blood Flow Restriction with low load exercise and Therapeutic Exercise in Tibial Fractures and Lower Extremity Fracture, sponsored by Denver Health and Hospital Authority. Recruiting at 1 site in United States. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-11-21.

Sponsored by Denver Health and Hospital Authority · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by May 2026, 5 months ago, but the record still lists the study as recruiting.
  • Started Nov 2024; still recruiting 2 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Study summary

This study will look at the effect of using a blood flow restriction device during low load strengthening exercises on patients with tibial shaft fractures, compared to patients performing exercise without the device. The study will compare muscle strength, muscle size, fracture healing, and return to normal function between the two groups.

Read the detailed description

This study will examine the effect of blood flow restriction (BFR) training in patients with lower extremity fractures. Patients with tibial shaft fractures will be assigned to either the BFR group or control group. The BFR group will perform exercises with a blood flow restriction device, which occludes venous blood flow in the limb, while performing strengthening exercises as directed by a Doctor of Physical Therapy. The control group will perform the exercises without the device, as is current standard practice in physical therapy. Blood flow restriction training has been shown to prevent strength loss and muscle atrophy after surgery or injury, and studies suggest that it increases biomarkers of bone metabolism and tissue healing. The goal of this study is to examine the use of BFR in trauma patients using a defined protocol, and compare fracture healing, muscle strength, muscle girth, and subjective physical function between groups.

02

Conditions studied

  • Tibial Fractures
  • Lower Extremity Fracture

Browse trials for

03

In context

Tibial Fractures

135 studies on the registry are indexed under Tibial Fractures; 37 are open to participants now.

This study's planned enrollment of 40 is below the median of 65 across 91 interventional studies indexed under Tibial Fractures.

Browse Tibial Fractures studies →

Lead sponsor

Denver Health and Hospital Authority is the lead sponsor of 84 studies on the registry; 4 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 8 (89%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult with closed tibial shaft fracture
  • Ability to begin physical therapy treatment within 2 weeks post-operatively

Exclusion criteria

Exclusion Criteria:

  • History of osteoporosis or osteopenia
  • Impaired circulation in the limb
  • Active deep vein thrombosis
  • Clotting disorders or other elevated risk of embolism
  • Sickle cell anemia
  • Infection in extremity
  • Renal compromise
  • Severe uncontrolled hypertension (SBP>180)
  • Lymphedema
  • Under age 18
  • Pregnancy
  • Prisoner
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (estimated)

Study arms

  • Experimental
    Blood flow restriction training

    Patients will perform exercises as directed by a Doctor of Physical Therapy with the use of blood flow restriction device

    Device: Blood Flow Restriction with low load exercise

  • Active comparator
    Traditional physical therapy

    Patients perform physical therapy exercises guided by a Doctor of Physical Therapy without the use of a blood flow restriction device, as is current standard practice.

    Other: Therapeutic Exercise

Interventions

  • DeviceBlood Flow Restriction with low load exercise

    Cuff/tourniquet will be applied to proximal leg at hip crease and inflated to 60-80% of limb occlusion pressure to decrease venous blood flow in the limb while performing exercise.

  • OtherTherapeutic Exercise

    Exercise performed at appropriate load as guided by physical therapist

06

What researchers measure

Primary outcomes

  1. Fracture healing

    Tibial shaft fracture healing as measured by Radiographic Union Score for Tibial (RUST) fractures

    Time frame: 6 weeks, 12 weeks, 6 months

Secondary outcomes

  1. Muscle strength

    Knee extension and ankle plantarflexion strength measured with a dynamometer

    Time frame: 2 weeks, 4 weeks, 6 weeks, 12 weeks, and 6 months

  2. Muscle girth

    Quadriceps and gastrocnemius muscle girth measured 15 cm above and below joint line

    Time frame: 2, 4, 6, 12 weeks and 6 months

  3. Physical function

    Subjective measure of function measured by Lower Extremity Functional Scale (LEFS)

    Time frame: 2, 6,12 weeks and 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 21, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06496035
Lead sponsor
Denver Health and Hospital Authority
Responsible party
Sponsor
First posted
Jul 11, 2024
Start date
Nov 1, 2024
Primary completion
May 31, 2026 (estimated)
Completion
May 31, 2026 (estimated)
Last update
Nov 21, 2025

Study contacts

Megan E Smith, PT, DPT
Contact
megan.smith@dhha.org
6513191730
Mathew A Haager, PT, DPT
Contact
mat.haager@dhha.org
5639407061
Megan E Smith, PT, DPT
principal investigator · Denver Health

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion